Efficacy Analysis of Combining Sintilimab with Neoadjuvant Chemotherapy in Treating Middle and Advanced Rectal Cancer Based on Big Data

Table 1

Clinical characteristics of 43 patients ().

Clinical data	Number of cases	Proportion (%)
Age
≤55 years	20	46.51
>55 years	23	53.49
Gender
Male	28	65.12
Female	15	34.88
Smoking
Yes	24	55.81
No	19	44.19
Broders grade
I	4	9.30
II	31	72.09
III	8	18.60
ECOG score
0-1 point	26	60.47
2 points	17	39.53
TNM stage
IIc	13	30.23
III	30	69.77